INSIGHTS ON DRUG DEVELOPMENT

• Developing A Quantitative Surrogate Peptide Assay

  Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.

• Get More From Less: AMP Chemistry Outperforms Hybrid Capture

  Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.

• A Fast And Simple ddPCR Assay For In-Depth AAV Characterization

  Achieve precise AAV characterization with a streamlined digital assay. This video illustrates a rapid, four-step workflow that delivers accurate empty-to-full ratios in under eight hours.

• Where Speed Meets Complexity In Bioprocess Development

  Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

• Accelerating Clinical Development: Modern Tools In Process Chemistry

  1/23/2025

  Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

• Streamline Drug Development With A Lab Informatics Platform

  8/13/2025

  Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.

• Closing The QC Gap For mAbs: Rapid Answers Without Compromising

  6/9/2026

  Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

• Patient-Centric Formulations In Pediatric Adherence

  11/13/2025

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success

  2/26/2025

  By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.